Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis.

PLoS pathogens

Kugadas A, Christiansen SH, Sankaranarayanan S, Surana NK, Gauguet S, Kunz R, Fichorova R, Vorup-Jensen T, Gadjeva M.
PMID: 27658245
PLoS Pathog. 2016 Sep 22;12(9):e1005855. doi: 10.1371/journal.ppat.1005855. eCollection 2016 Sep.

The existence of the ocular microbiota has been reported but functional analyses to evaluate its significance in regulating ocular immunity are currently lacking. We compared the relative contribution of eye and gut commensals in regulating the ocular susceptibility to...

Cite
Kugadas A, Christiansen SH, Sankaranarayanan S, et al. Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis. PLoS Pathog. 2016;12(9):e1005855doi: 10.1371/journal.ppat.1005855.
Kugadas, A., Christiansen, S. H., Sankaranarayanan, S., Surana, N. K., Gauguet, S., Kunz, R., Fichorova, R., Vorup-Jensen, T., & Gadjeva, M. (2016). Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis. PLoS pathogens, 12(9), e1005855. https://doi.org/10.1371/journal.ppat.1005855
Kugadas, Abirami, et al. "Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis." PLoS pathogens vol. 12,9 (2016): e1005855. doi: https://doi.org/10.1371/journal.ppat.1005855
Kugadas A, Christiansen SH, Sankaranarayanan S, Surana NK, Gauguet S, Kunz R, Fichorova R, Vorup-Jensen T, Gadjeva M. Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis. PLoS Pathog. 2016 Sep 22;12(9):e1005855. doi: 10.1371/journal.ppat.1005855. eCollection 2016 Sep. PMID: 27658245; PMCID: PMC5033354.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor and mood in perimenopausal depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021;300:145-149doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of affective disorders, 300145-149. https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived neurotrophic factor and mood in perimenopausal depression." Journal of affective disorders vol. 300 (2021): 145-149. doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor and mood in perimenopausal depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021;300:145-149doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of affective disorders, 300145-149. https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived neurotrophic factor and mood in perimenopausal depression." Journal of affective disorders vol. 300 (2021): 145-149. doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor and mood in perimenopausal depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021;300:145-149doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of affective disorders, 300145-149. https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived neurotrophic factor and mood in perimenopausal depression." Journal of affective disorders vol. 300 (2021): 145-149. doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor and mood in perimenopausal depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021;300:145-149doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of affective disorders, 300145-149. https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived neurotrophic factor and mood in perimenopausal depression." Journal of affective disorders vol. 300 (2021): 145-149. doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age.

The Journal of pediatrics

Belfort MB, Ramel SE, Martin CR, Fichorova R, Kuban KCK, Heeren T, Fry RC, O'Shea TM.
PMID: 34508750
J Pediatr. 2022 Jan;240:37-43.e1. doi: 10.1016/j.jpeds.2021.09.006. Epub 2021 Sep 08.

OBJECTIVE: To examine associations of systemic inflammation with growth outcomes at neonatal intensive care unit discharge or transfer among infants with extremely low gestational ages.STUDY DESIGN: We studied 850 infants at born at 23-27 weeks of gestation. We defined...

Cite
Belfort MB, Ramel SE, Martin CR, et al. Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age. J Pediatr. 2021;240:37-43.e1doi: 10.1016/j.jpeds.2021.09.006.
Belfort, M. B., Ramel, S. E., Martin, C. R., Fichorova, R., Kuban, K. C. K., Heeren, T., Fry, R. C., & O'Shea, T. M. (2022). Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age. The Journal of pediatrics, 24037-43.e1. https://doi.org/10.1016/j.jpeds.2021.09.006
Belfort, Mandy B, et al. "Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age." The Journal of pediatrics vol. 240 (2022): 37-43.e1. doi: https://doi.org/10.1016/j.jpeds.2021.09.006
Belfort MB, Ramel SE, Martin CR, Fichorova R, Kuban KCK, Heeren T, Fry RC, O'Shea TM. Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age. J Pediatr. 2022 Jan;240:37-43.e1. doi: 10.1016/j.jpeds.2021.09.006. Epub 2021 Sep 08. PMID: 34508750; PMCID: PMC8712377.
Copy Download .nbib Format: NLM
Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.

American journal of obstetrics and gynecology

Gustin AT, Thurman AR, Chandra N, Schifanella L, Alcaide M, Fichorova R, Doncel GF, Gale M, Klatt NR.
PMID: 34560047
Am J Obstet Gynecol. 2021 Sep 22; doi: 10.1016/j.ajog.2021.09.018. Epub 2021 Sep 22.

BACKGROUND: Bacterial vaginosis-a condition defined by a shift from Lactobacillus dominance to a polymicrobial, anaerobic bacterial community-increases the risk of acquiring sexually transmitted infections and other complications of the female reproductive tract. Antibiotic treatment frequently fails to return the...

Cite
Gustin AT, Thurman AR, Chandra N, et al. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis. Am J Obstet Gynecol. 2021;doi: 10.1016/j.ajog.2021.09.018.
Gustin, A. T., Thurman, A. R., Chandra, N., Schifanella, L., Alcaide, M., Fichorova, R., Doncel, G. F., Gale, M., & Klatt, N. R. (2021). Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis. American journal of obstetrics and gynecology, . https://doi.org/10.1016/j.ajog.2021.09.018
Gustin, Andrew T, et al. "Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis." American journal of obstetrics and gynecology vol. (2021). doi: https://doi.org/10.1016/j.ajog.2021.09.018
Gustin AT, Thurman AR, Chandra N, Schifanella L, Alcaide M, Fichorova R, Doncel GF, Gale M, Klatt NR. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis. Am J Obstet Gynecol. 2021 Sep 22; doi: 10.1016/j.ajog.2021.09.018. Epub 2021 Sep 22. PMID: 34560047.
Copy Download .nbib Format: NLM
Brain-derived Neurotrophic Factor and Mood in Perimenopausal Depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23; doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived Neurotrophic Factor and Mood in Perimenopausal Depression. J Affect Disord. 2021;doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived Neurotrophic Factor and Mood in Perimenopausal Depression. Journal of affective disorders, . https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived Neurotrophic Factor and Mood in Perimenopausal Depression." Journal of affective disorders vol. (2021). doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived Neurotrophic Factor and Mood in Perimenopausal Depression. J Affect Disord. 2021 Dec 23; doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor and mood in perimenopausal depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021;300:145-149doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of affective disorders, 300145-149. https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived neurotrophic factor and mood in perimenopausal depression." Journal of affective disorders vol. 300 (2021): 145-149. doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor and mood in perimenopausal depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021;300:145-149doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of affective disorders, 300145-149. https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived neurotrophic factor and mood in perimenopausal depression." Journal of affective disorders vol. 300 (2021): 145-149. doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age.

The Journal of pediatrics

Belfort MB, Ramel SE, Martin CR, Fichorova R, Kuban KCK, Heeren T, Fry RC, O'Shea TM.
PMID: 34508750
J Pediatr. 2022 Jan;240:37-43.e1. doi: 10.1016/j.jpeds.2021.09.006. Epub 2021 Sep 08.

OBJECTIVE: To examine associations of systemic inflammation with growth outcomes at neonatal intensive care unit discharge or transfer among infants with extremely low gestational ages.STUDY DESIGN: We studied 850 infants at born at 23-27 weeks of gestation. We defined...

Cite
Belfort MB, Ramel SE, Martin CR, et al. Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age. J Pediatr. 2021;240:37-43.e1doi: 10.1016/j.jpeds.2021.09.006.
Belfort, M. B., Ramel, S. E., Martin, C. R., Fichorova, R., Kuban, K. C. K., Heeren, T., Fry, R. C., & O'Shea, T. M. (2022). Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age. The Journal of pediatrics, 24037-43.e1. https://doi.org/10.1016/j.jpeds.2021.09.006
Belfort, Mandy B, et al. "Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age." The Journal of pediatrics vol. 240 (2022): 37-43.e1. doi: https://doi.org/10.1016/j.jpeds.2021.09.006
Belfort MB, Ramel SE, Martin CR, Fichorova R, Kuban KCK, Heeren T, Fry RC, O'Shea TM. Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age. J Pediatr. 2022 Jan;240:37-43.e1. doi: 10.1016/j.jpeds.2021.09.006. Epub 2021 Sep 08. PMID: 34508750.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor and mood in perimenopausal depression.

Journal of affective disorders

Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H.
PMID: 34954335
J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23.

BACKGROUND: Previous work implicates high pro-inflammatory biomarkers in mood disturbance and low brain-derived neurotrophic factor (BDNF) levels in major depression. However, in hormonally-sensitive premenstrual dysphoric disorder (PMDD), BDNF levels are higher when mood is worse. Perimenopausal depression has not...

Cite
Harder JA, Fichorova RN, Srivastava A, et al. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021;300:145-149doi: 10.1016/j.jad.2021.12.092.
Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2021). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of affective disorders, 300145-149. https://doi.org/10.1016/j.jad.2021.12.092
Harder, Jessica A, et al. "Brain-derived neurotrophic factor and mood in perimenopausal depression." Journal of affective disorders vol. 300 (2021): 145-149. doi: https://doi.org/10.1016/j.jad.2021.12.092
Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. Brain-derived neurotrophic factor and mood in perimenopausal depression. J Affect Disord. 2021 Dec 23;300:145-149. doi: 10.1016/j.jad.2021.12.092. Epub 2021 Dec 23. PMID: 34954335.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries